Glucocorticoid discontinuation in patients with rheumatoid arthritis who initiated biologic or ta...
September 30, 2026
Share
Glucocorticoid discontinuation in patients with rheumatoid arthritis who initiated biologic or targeted synthetic agents: a real-world population-based analysis.
Cellular and proteomic changes following administration of peresolimab in patients with rheumatoi...
September 30, 2026
Share
Cellular and proteomic changes following administration of peresolimab in patients with rheumatoid arthritis: a post-hoc analysis of a randomised phase 2a trial.
Reporting health-related quality of life in randomised clinical trials evaluating adjuvant system...
September 30, 2026
Share
Reporting health-related quality of life in randomised clinical trials evaluating adjuvant systemic therapy: recommendations of Common-Sense Oncology and the European Organisation for Research and Treatment of Cancer.
Spatial modulation of RAF by RAF/MEK glue enables full-dose combination with pan-RAF inhibitor an...
September 30, 2026
Share
Spatial modulation of RAF by RAF/MEK glue enables full-dose combination with pan-RAF inhibitor and potent RAS-mutant tumor-selective MAPK and growth inhibition.
Final results and predictive biomarkers of response and long-term outcomes with first-line pembro...
September 30, 2026
Share
Final results and predictive biomarkers of response and long-term outcomes with first-line pembrolizumab monotherapy in advanced renal cell carcinoma in the phase II KEYNOTE-427 study.
Population-level shift in ex vivo artemisinin susceptibility in Plasmodium falciparum: comparison...
September 30, 2026
Share
Population-level shift in ex vivo artemisinin susceptibility in Plasmodium falciparum: comparison of 2014-2015 and 2022-2024 surveys in northern Uganda.
Glycemic and psychosocial outcomes of automated insulin delivery in older and high-risk populatio...
September 30, 2026
Share
Glycemic and psychosocial outcomes of automated insulin delivery in older and high-risk populations with type 1 diabetes: a systematic review and meta-analysis.
Comparative Short-Term Prognostic Discrimination of the 2026 AHA/ACC and 2019 ESC Risk Classifica...
September 30, 2026
Share
Comparative Short-Term Prognostic Discrimination of the 2026 AHA/ACC and 2019 ESC Risk Classifications in Hospitalized Acute Pulmonary Embolism: A Retrospective Two-Campus Cohort Study.
Carotid Plaque-Reporting and Data System for Predicting In-Hospital Ischemic Stroke After Coronar...
September 30, 2026
Share
Carotid Plaque-Reporting and Data System for Predicting In-Hospital Ischemic Stroke After Coronary Artery Bypass Graft-Containing Cardiac Surgery: Complementary Value Beyond Stenosis Severity.
Artificial Intelligence-Derived Electrocardiographic Age Enhances Stroke Risk Stratification in P...
September 30, 2026
Share
Artificial Intelligence-Derived Electrocardiographic Age Enhances Stroke Risk Stratification in Patients With Atrial Fibrillation With a CHA2DS2-VA Score of 1.
Upadacitinib Is Associated with the Lowest Risk of Treatment Failure Among Advanced Therapies for...
September 30, 2026
Share
Upadacitinib Is Associated with the Lowest Risk of Treatment Failure Among Advanced Therapies for Ulcerative Colitis: A Real-World Administrative Claims Study.
Effect of Preoperative Ocular Surface Optimization on Biometric Accuracy and Refractive Outcomes ...
September 30, 2026
Share
Effect of Preoperative Ocular Surface Optimization on Biometric Accuracy and Refractive Outcomes After Cataract Surgery: A Systematic Review with Narrative and Exploratory Quantitative Synthesis.
Analysis of outcomes of nab-paclitaxel compared to other taxanes in early breast cancer: A study ...
September 30, 2026
Share
Analysis of outcomes of nab-paclitaxel compared to other taxanes in early breast cancer: A study revealing the critical role of calendar-time bias in real-world drug comparisons.
Real-world implementation of a decision aid for treatment decisions in metastatic pancreatic canc...
September 30, 2026
Share
Real-world implementation of a decision aid for treatment decisions in metastatic pancreatic cancer: a prospective multicenter study across expert centers.